Table 1 General information of included population
From: Outcomes following conization and factors on HPV regression among young females in Wuxi
parameters | Classification | P50 / N (%) |
|---|---|---|
Age(years) | ≤ 25 | 21 (18,25) / 42 (10.5) |
26–30 | 27 (26,30) / 148 (37) | |
31–35 | 33 (31,35) / 210 (52.5) | |
BMI (kg/m2) |  | 24.35 ± 4.91 |
Marriage | Married | 224 (56) |
Unmarried | 176 (44) | |
Gravidity |  | 2.45 ± 1.26 |
Parity |  | 1.14 ± 0.66 |
Duration of sexual life (month) | Â | 38 (10, 120) |
HPV vaccination | Vaccinated | 168 (42) |
Unvaccinated | 232 (58) | |
Contraceptive method | Intrauterine ring | 62 (15.5) |
Condom | 86 (21.5) | |
Oral contraceptive | 24 (6.0) | |
No contraception | 228 (57) | |
HPV status | HPV16/18 | 130 (32.5) |
Other Hr-HPV (Non16/18) | 260 (65.0) | |
Negative/unknown | 10 (2.5) | |
cytology | NILM | 102 (25.5) |
ASC-US | 190 (47.5) | |
LSIL | 82 (20.5) | |
≥HSIL | 26 (6.5) | |
cervical biopsy under colposcope | ≤LSIL | 258 (72.8) |
HSIL | 94 (26.6) | |
Cervical Cancer | 2 (0.6) | |
Pathology after conization/LEEP (N = 92) | ≤LSIL | 28 (30.4) |
HSIL | 60 (65.3) | |
Cervical Cancer | 4 (4.3) |